Molasses, Antox® and EN-FLORAX® decreased antibody decay rate and enhanced response to a very virulent infectious bursal disease virus and Newcastle disease vaccine La Sota in ISA Brown chicks.
Aliyu Andamin, Paul Abdu, Ochuko Orakpoghenor, Talatu Markus, Sunday Oladele, Felix Akade, Tagang Aluwong
{"title":"Molasses, Antox® and EN-FLORAX® decreased antibody decay rate and enhanced response to a very virulent infectious bursal disease virus and Newcastle disease vaccine La Sota in ISA Brown chicks.","authors":"Aliyu Andamin, Paul Abdu, Ochuko Orakpoghenor, Talatu Markus, Sunday Oladele, Felix Akade, Tagang Aluwong","doi":"10.1080/15321819.2022.2036188","DOIUrl":null,"url":null,"abstract":"<p><p>This study evaluated the effects of molasses, Antox® and EN-FLORAX® on antibody (Ab) decay and response to a very virulent IBD virus (vvIBDV) and ND vaccine La Sota (NDVLS) in ISA Brown chicks. Five groups, (A, B, C, D and E) of 50 chicks each were used for the study. Groups A, B and C were supplemented with molasses, Antox® and EN-FLORAX®, respectively, orally from 1 to 49 days, and inoculated with a vvIBDV at 28 days of age. Groups D, and E were positive, and negative controls, respectively. At 35 days of age, all groups were vaccinated with NDVLS. Antibody (Ab) titers to vvIBDV, and NDV, were determined by indirect enzyme linked immunosorbent assay (I-ELISA), and hemagglutination-inhibition (HI) tests, respectively. Results revealed significantly (P < .05) decreased Ab decay rates in supplemented groups (A, B, and C) compared to controls (D and E) up to day 28. There were significantly (P < .05) higher mean IBDV and ND HI Ab titers in supplemented groups compared to D with the highest in A up to day 49. Molasses, Antox®, and EN-FLORAX® decreased rate of Ab decay, elicited stronger Ab response against vvIBDV and production of protective NDVLS HI Ab titers.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":"43 5","pages":"546-556"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunoassay & immunochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15321819.2022.2036188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/2/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 1
Abstract
This study evaluated the effects of molasses, Antox® and EN-FLORAX® on antibody (Ab) decay and response to a very virulent IBD virus (vvIBDV) and ND vaccine La Sota (NDVLS) in ISA Brown chicks. Five groups, (A, B, C, D and E) of 50 chicks each were used for the study. Groups A, B and C were supplemented with molasses, Antox® and EN-FLORAX®, respectively, orally from 1 to 49 days, and inoculated with a vvIBDV at 28 days of age. Groups D, and E were positive, and negative controls, respectively. At 35 days of age, all groups were vaccinated with NDVLS. Antibody (Ab) titers to vvIBDV, and NDV, were determined by indirect enzyme linked immunosorbent assay (I-ELISA), and hemagglutination-inhibition (HI) tests, respectively. Results revealed significantly (P < .05) decreased Ab decay rates in supplemented groups (A, B, and C) compared to controls (D and E) up to day 28. There were significantly (P < .05) higher mean IBDV and ND HI Ab titers in supplemented groups compared to D with the highest in A up to day 49. Molasses, Antox®, and EN-FLORAX® decreased rate of Ab decay, elicited stronger Ab response against vvIBDV and production of protective NDVLS HI Ab titers.
期刊介绍:
The Journal of Immunoassay & Immunochemistry is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of immunoassay and immunochemistry, as well as selected aspects of immunology. They include receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, biological markers of ligand-receptor interaction, in vivo and in vitro diagnostic reagents and techniques, diagnosis of AIDS, point-of-care testing, clinical immunology, antibody isolation and purification, and others.